Zhao X, Wang Y, Li J, Liu W, Yang Y, Qiao Y, Liao J, Chen M, Li D, Wu B, Huang D, Wu D. A machine-learning-derived online prediction model for depression risk in COPD patients: A retrospective cohort study from CHARLS.
J Affect Disord 2025;
377:284-293. [PMID:
39988142 DOI:
10.1016/j.jad.2025.02.063]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2024] [Revised: 02/14/2025] [Accepted: 02/17/2025] [Indexed: 02/25/2025]
Abstract
BACKGROUND
Depression associated with Chronic Obstructive Pulmonary Disease (COPD) is a detrimental complication that significantly impairs patients' quality of life. This study aims to develop an online predictive model to estimate the risk of depression in COPD patients.
METHODS
This study included 2921 COPD patients from the 2018 China Health and Retirement Longitudinal Study (CHARLS), analyzing 36 behavioral, health, psychological, and socio-demographic indicators. LASSO regression filtered predictive factors, and six machine learning models-Logistic Regression, Support Vector Machine, Multilayer Perceptron, LightGBM, XGBoost, and Random Forest-were applied to identify the best model for predicting depression risk in COPD patients. Temporal validation used 2013 CHARLS data. We developed a personalized, interpretable risk prediction platform using SHAP.
RESULTS
A total of 2921 patients with COPD were included in the analysis, of whom 1451 (49.7 %) presented with depressive symptoms. 11 variables were selected to develop 6 machine learning models. Among these, the XGBoost model exhibited exceptional predictive performance in terms of discrimination, calibration, and clinical applicability, with an AUROC range of 0.747-0.811. In validation sets encompassing diverse population characteristics, XGBoost achieved the highest accuracy (70.63 %), sensitivity (59.05 %), and F1 score (63.17 %).
LIMITATIONS
The target population for the model is COPD patients. And the clinical benefits of interventions based on the prediction results remain uncertain.
CONCLUSION
We developed an online prediction platform for clinical application, allowing healthcare professionals to swiftly and efficiently evaluate the risk of depression in COPD patients, facilitating timely interventions and treatments.
Collapse